These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 15542729)

  • 1. Neuromechanism of developing methamphetamine psychosis: a neuroimaging study.
    Iyo M; Sekine Y; Mori N
    Ann N Y Acad Sci; 2004 Oct; 1025():288-95. PubMed ID: 15542729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methamphetamine users in sustained abstinence: a proton magnetic resonance spectroscopy study.
    Nordahl TE; Salo R; Natsuaki Y; Galloway GP; Waters C; Moore CD; Kile S; Buonocore MH
    Arch Gen Psychiatry; 2005 Apr; 62(4):444-52. PubMed ID: 15809412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methamphetamine-related psychiatric symptoms and reduced brain dopamine transporters studied with PET.
    Sekine Y; Iyo M; Ouchi Y; Matsunaga T; Tsukada H; Okada H; Yoshikawa E; Futatsubashi M; Takei N; Mori N
    Am J Psychiatry; 2001 Aug; 158(8):1206-14. PubMed ID: 11481152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural and metabolic brain changes in the striatum associated with methamphetamine abuse.
    Chang L; Alicata D; Ernst T; Volkow N
    Addiction; 2007 Apr; 102 Suppl 1():16-32. PubMed ID: 17493050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced midbrain dopamine transporter binding in male adolescents with attention-deficit/hyperactivity disorder: association between striatal dopamine markers and motor hyperactivity.
    Jucaite A; Fernell E; Halldin C; Forssberg H; Farde L
    Biol Psychiatry; 2005 Feb; 57(3):229-38. PubMed ID: 15691523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolite alterations in basal ganglia associated with methamphetamine-related psychiatric symptoms. A proton MRS study.
    Sekine Y; Minabe Y; Kawai M; Suzuki K; Iyo M; Isoda H; Sakahara H; Ashby CR; Takei N; Mori N
    Neuropsychopharmacology; 2002 Sep; 27(3):453-61. PubMed ID: 12225702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attentional control and brain metabolite levels in methamphetamine abusers.
    Salo R; Nordahl TE; Natsuaki Y; Leamon MH; Galloway GP; Waters C; Moore CD; Buonocore MH
    Biol Psychiatry; 2007 Jun; 61(11):1272-80. PubMed ID: 17097074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study of association between alpha-synuclein gene polymorphism and methamphetamine psychosis/dependence.
    Kobayashi H; Ide S; Hasegawa J; Ujike H; Sekine Y; Ozaki N; Inada T; Harano M; Komiyama T; Yamada M; Iyo M; Shen HW; Ikeda K; Sora I
    Ann N Y Acad Sci; 2004 Oct; 1025():325-34. PubMed ID: 15542733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustained effects of ecstasy on the human brain: a prospective neuroimaging study in novel users.
    de Win MM; Jager G; Booij J; Reneman L; Schilt T; Lavini C; Olabarriaga SD; den Heeten GJ; van den Brink W
    Brain; 2008 Nov; 131(Pt 11):2936-45. PubMed ID: 18842607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prevalence of psychotic symptoms among methamphetamine users.
    McKetin R; McLaren J; Lubman DI; Hides L
    Addiction; 2006 Oct; 101(10):1473-8. PubMed ID: 16968349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spontaneous recurrence of methamphetamine-induced paranoid-hallucinatory states in female subjects: susceptibility to psychotic states and implications for relapse of schizophrenia.
    Yui K; Ikemoto S; Goto K; Nishijima K; Yoshino T; Ishiguro T
    Pharmacopsychiatry; 2002 Mar; 35(2):62-71. PubMed ID: 11951147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Why is parkinsonism not a feature of human methamphetamine users?
    Moszczynska A; Fitzmaurice P; Ang L; Kalasinsky KS; Schmunk GA; Peretti FJ; Aiken SS; Wickham DJ; Kish SJ
    Brain; 2004 Feb; 127(Pt 2):363-70. PubMed ID: 14645148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impulsivity and positive psychotic symptoms influence hostility in methamphetamine users.
    Lapworth K; Dawe S; Davis P; Kavanagh D; Young R; Saunders J
    Addict Behav; 2009 Apr; 34(4):380-5. PubMed ID: 19097704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of dopamine transporter loss in the orbitofrontal and dorsolateral prefrontal cortices with methamphetamine-related psychiatric symptoms.
    Sekine Y; Minabe Y; Ouchi Y; Takei N; Iyo M; Nakamura K; Suzuki K; Tsukada H; Okada H; Yoshikawa E; Futatsubashi M; Mori N
    Am J Psychiatry; 2003 Sep; 160(9):1699-701. PubMed ID: 12944350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between N-acetyl-aspartate in gray and white matter of abstinent methamphetamine abusers and their history of drug abuse: a proton magnetic resonance spectroscopy study.
    Sung YH; Cho SC; Hwang J; Kim SJ; Kim H; Bae S; Kim N; Chang KH; Daniels M; Renshaw PF; Lyoo IK
    Drug Alcohol Depend; 2007 Apr; 88(1):28-35. PubMed ID: 17084995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic variants of D2 but not D3 or D4 dopamine receptor gene are associated with rapid onset and poor prognosis of methamphetamine psychosis.
    Ujike H; Katsu T; Okahisa Y; Takaki M; Kodama M; Inada T; Uchimura N; Yamada M; Iwata N; Sora I; Iyo M; Ozaki N; Kuroda S
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Jun; 33(4):625-9. PubMed ID: 19275926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute exacerbation of paranoid psychotic state after long-term abstinence in patients with previous methamphetamine psychosis.
    Sato M; Chen CC; Akiyama K; Otsuki S
    Biol Psychiatry; 1983 Apr; 18(4):429-40. PubMed ID: 6860719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical features of sensitization to methamphetamine observed in patients with methamphetamine dependence and psychosis.
    Ujike H; Sato M
    Ann N Y Acad Sci; 2004 Oct; 1025():279-87. PubMed ID: 15542728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An exploratory analysis of neurocognition in methamphetamine-induced psychotic disorder and paranoid schizophrenia.
    Jacobs E; Fujii D; Schiffman J; Bello I
    Cogn Behav Neurol; 2008 Jun; 21(2):98-103. PubMed ID: 18541986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A polymorphism of DRD2 gene and brain atrophy in methamphetamine psychosis.
    Harano M; Uchimura N; Abe H; Ishibashi M; Iida N; Yanagimoto K; Tanaka T; Maeda H; Sora I; Iyo M; Komiyama T; Yamada M; Sekine Y; Inada T; Ozaki N; Ujike H
    Ann N Y Acad Sci; 2004 Oct; 1025():307-15. PubMed ID: 15542731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.